Malignancy Center offers specialized programs for the treatment of leukemia, lymphoma, histiocytosis, and lymphadenopathy through Dana-Farber/Boston Children's Cancer and Blood Disorders Center, an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children's Hospital. Our center played a key role in refining treatment for childhood leukemia, resulting in today's cure rates of more than 90 percent
for pediatric acute lymphoblastic leukemia, and we continue to lead
high-impact clinical trials designed to increase cure rates and decrease
treatment-related toxicities for long-term survivors.
Phone: 617-632-5508Online form: Request an appointment
World class cancer care at the #1 children's hospital
Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.